Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase 2 study of endoxifen in breast cancer patients who are refractory to tamoxifen

Next Previous
X
Search
Trial Profile

A phase 2 study of endoxifen in breast cancer patients who are refractory to tamoxifen

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 11 Sep 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Endoxifen (Primary)
  • Indications Breast cancer
  • Focus Therapeutic Use

    • Most Recent Events

    • 13 Jul 2018 According to an Atossa Genetics media release, the company expects to initiate this study in H2 2018.
    • 28 Dec 2017 According to an Atossa Genetics media release, the company expects to initiate this study in the first quarter of 2018 and the company plans to complete the study in 2018.
    • 11 May 2017 According to an Atossa Genetics medi release, the company anticipates commencing a this phase 2 study in the second half of 2017.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top